We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan

By MedImaging International staff writers
Posted on 02 Apr 2024
Image: TAM-Sense is a new technology that makes it possible to see inflammation on an MRI scan (Photo courtesy of Pixabay)
Image: TAM-Sense is a new technology that makes it possible to see inflammation on an MRI scan (Photo courtesy of Pixabay)

Macrophages are important immune cells that play a crucial role in both the body's normal inflammatory response and also comprise a significant portion of solid tumors. Given that the density of macrophages within a tumor significantly influences its response to treatments, the capability to measure them noninvasively can offer a significant advantage in determining the most suitable therapeutic approach. Now, researchers are developing and clinically testing imaging technologies that can noninvasively examine and quantify these immune cells present in tumors.

The technology, called TAM-Sense, being tested at the University of California San Diego School of Medicine (La Jolla, CA, USA) works by feeding macrophages tiny drops of a dye that can be detected by magnetic resonance imaging (MRI). The TAM-Sense agent is a fluid composed of very tiny drops of a biologically inert fluorocarbon dye, integrates into the bloodstream upon injection. The macrophages detect and engulf these droplets, then collect at the inflammation sites, making it possible to visualize the dye inside them with a specifically modified MRI scanner. This process is similar to the routine MRI scan experience from a patient's perspective. The phase I clinical trial aims to explore TAM-Sense's effectiveness in individuals with recurrent head and neck tumors, marking its first clinical study.

TAM-Sense's potential extends beyond oncology, offering possible applications across various conditions characterized by significant inflammation, including autoimmune diseases, cardiovascular disorders, and infectious diseases. Given the tendency of macrophages to accumulate at pain sites within the body, this imaging technique promises to enhance the accuracy of pain management strategies by precisely locating these areas. Further, the researchers are planning to modify TAM-Sense for compatibility with positron emission tomography (PET) scanning, facilitating comprehensive body imaging. MRI scores over PET in providing high-resolution images over limited fields of view, while PET is superior in full-body scanning for disease detection. However, the PET approach will need further preclinical testing before it can be used on patients.

“Visualizing a patient’s inflammatory sites throughout the body will be invaluable for accurate clinical diagnosis and for planning precise therapeutic interventions,” said Eric Ahrens, Ph.D., a professor in the Department of Radiology at UC San Diego School of Medicine. “Current approaches using biopsies are invasive, and some tumors are inaccessible to biopsy. There is an urgent need for new, whole-body imaging technologies.”

Related Links:
UC San Diego

Ultrasonic Pocket Doppler
SD1
Pocket Fetal Doppler
CONTEC10C/CL
Silver Member
X-Ray QA Meter
T3 AD Pro
Portable Color Doppler Ultrasound System
S5000

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.